Prognostic Impact of mRNA Expression Levels of HER1–4 (ERBB1–4) in Patients with Locally Advanced Rectal Cancer

Background. No predictive or prognostic biomarker is available for patients with locally advanced rectal cancer (LARC) undergoing perioperative chemoradiotherapy (CRT). Members of the human epidermal growth factor receptor (HER) family of receptor tyrosine kinases EGFR (HER1, ERBB1), HER2 (ERBB2), H...

Descripción completa

Detalles Bibliográficos
Autores principales: Kripp, Melanie, Merx, Kirsten, Wirtz, Ralph Markus, Gaiser, Timo, Eidt, Sebastian, Schwaab, Juliana, Post, Stefan, Wenz, Frederik, Hochhaus, Andreas, Hofheinz, Ralf-Dieter, Erben, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004041/
https://www.ncbi.nlm.nih.gov/pubmed/27610130
http://dx.doi.org/10.1155/2016/3481578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004041/
https://www.ncbi.nlm.nih.gov/pubmed/27610130
http://dx.doi.org/10.1155/2016/3481578

Ejemplares similares